Egypt Immuno-Oncology Research Review Issue 9

In this issue:
  -  Impact of poverty and neighbourhood opportunity on young CAR T-cell recipients
  -  Big ICI response data identifies novel potential targets
  -  Perception of prognosis, QOL and distress in CAR T-cell recipients
  -  Pneumonitis risk in ICI-treated NSCLC with pre-existing ILD
  -  ICI effectiveness in advanced oesophageal squamous cell carcinoma
  -  ICI durability after cessation in metastatic Merkel cell carcinoma
  -  Pucotenlimab for locally advanced or metastatic melanoma
  -  Pembrolizumab vs. chemotherapy in nasopharyngeal cancer
  -  Outcome differences for ICIs according to infusion timing in advanced NSCLC
  -  Polyvalent vaccine + bevacizumab for recurrent ovarian cancer: long-term outcomes

Download PDF Subscribe